Rani Therapeutics Holdings, Inc. · NASDAQ:RANI
The Vanguard Group reported a 5.23% stake in Rani Therapeutics Holdings, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Jan 30, 2026
The Vanguard Group reported a 5.23% stake in Rani Therapeutics Holdings, Inc., 5,109,368 shares, as a passive investor on Dec 31, 2025. Filed Jan 30, 2026 (Schedule 13G).
- Stake
- 5.23%
- Shares
- 5,109,368
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 5.23% | 5,109,368 |
Source
Related
- Rani Therapeutics Holdings, Inc.
- The Vanguard Group
- Rani Therapeutics Holdings, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Form 4 · Imran Talat · Sep 29, 2026
- Form 4 · Javadi Alireza · Sep 29, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Schedule 13G/A · Vanguard Capital Management LLC · Jul 31, 2026
- Form 4 · Imran Mir A · Jul 23, 2026